Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Biguanides × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ketosis 1 Insulin Resistance 1 Glioma 1 Glioblastoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Cisplatin 461 Radiotherapy 336 Cyclophosphamide 320 Carboplatin 317 Paclitaxel 296 Capecitabine 296 Oxaliplatin 288 Docetaxel 276 Gemcitabine 274 Fluorouracil 250 apatinib 227 Drug Therapy 227 Bevacizumab 211 camrelizumab 190 Etoposide 177 Irinotecan 161 Doxorubicin 155 Leucovorin 136 Dexamethasone 136 Cytarabine 130 Blood Specimen Collection 130 pembrolizumab 123 Neoadjuvant Therapy 122 sintilimab 117 Pemetrexed 117 anlotinib 115 toripalimab 112 Rituximab 112 S 1 (combination) 111 Surgical Procedures, Operative 110

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02149459 2017-10-27

SMC 0712-13

Sheba Medical Center

Phase 1 Unknown

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Insulin Resistance, Ketosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡